Sprint is still sweating out regulatory approval for its would-be merger with T-Mobile.
* This article was originally published here
Friday 31 May 2019
New algorithm may help people store more pictures, share videos faster
The world produces about 2.5 quintillion bytes of data every day. Storing and transferring all of this enormous—and constantly growing—number of images, videos, Tweets, and other forms of data is becoming a significant challenge, one that threatens to undermine the growth of the internet and thwart the introduction of new technologies, such as the Internet of Things.
* This article was originally published here
* This article was originally published here
Quick liquid packaging: Encasing water silhouettes in 3-D polymer membranes for lab-in-a-drop experiments
The ability to confine water in an enclosed compartment without directly manipulating it or using rigid containers is an attractive possibility. In a recent study, Sara Coppola and an interdisciplinary research team in the departments of Biomaterials, Intelligent systems, Industrial Production Engineering and Advanced Biomaterials for Healthcare in Italy, proposed a water-based, bottom-up approach to encase facile, short-lived water silhouettes in a custom-made adaptive suit.
* This article was originally published here
* This article was originally published here
Native plant species may be at greater risk from climate change than non-natives
As spring advances across the Midwest, a new study looking at blooming flowers suggests that non-native plants might outlast native plants in the region due to climate change.
* This article was originally published here
* This article was originally published here
Defense against wireless attacks using a deep neural network and game theory
A growing number of devices are now connected to the internet and are capable of collecting, sending and receiving data. This interconnection between devices, referred to as the Internet of Things (IoT), poses serious security threats, as cyberattackers can now target computers and smartphones, but also a vast array of other devices, such as tablets, smart watches, smart home systems, transportation systems and so on.
* This article was originally published here
* This article was originally published here
Facebook loses bid to block landmark ECJ data security hearing
Ireland's supreme court on Friday dismissed a bid by Facebook to block a landmark data security case from progressing to the European Court of Justice.
* This article was originally published here
* This article was originally published here
Seven key health measures help predict future risk of heart disease
Seven key measures of heart health may help predict future risk of cardiovascular disease, according to researchers. They added that improving these measures may also help decrease the risk of CVD in the future.
* This article was originally published here
* This article was originally published here
'Miracle baby': Woman gets pregnant after having fallopian tubes removed
Elizabeth Kough had been pregnant before. She knew how it felt. She just couldn't believe it had happened this time.
* This article was originally published here
* This article was originally published here
New organic flow battery brings decomposing molecules back to life
After years of making progress on an organic aqueous flow battery, Harvard University researchers ran into a problem: the organic anthraquinone molecules that powered their ground-breaking battery were slowly decomposing over time, reducing the long-term usefulness of the battery.
* This article was originally published here
* This article was originally published here
Pancreatic cancer specialist explains treatment advances and challenges
With Alex Trebek's recent announcement that his pancreatic cancer is in remission, many people have wondered if this difficult cancer is now easier to treat. Pancreatic cancer remains a major cancer killer, but advances are happening.
* This article was originally published here
* This article was originally published here
How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to chronic heart failure pathology. About 6 million people in the United States and 23 million worldwide suffer from this end-stage disease that involves dysfunction of the heart, a change that clinicians call cardiac remodeling. Despite medical advances, 2 to 17 percent of patients die within one year after a heart attack due to failure to resolve inflammation. More than 50 percent die within five years.
* This article was originally published here
* This article was originally published here
Outsmarting deep fakes: AI-driven imaging system protects authenticity
To thwart sophisticated methods of altering photos and video, researchers at the NYU Tandon School of Engineering have demonstrated an experimental technique to authenticate images throughout the entire pipeline, from acquisition to delivery, using artificial intelligence (AI).
* This article was originally published here
* This article was originally published here
Research deepens understanding of gut bacteria's connections to human health, disease
Researchers at Oregon State University have made an important advance in understanding the roles that gut bacteria play in human health.
* This article was originally published here
* This article was originally published here
Entrectinib gets edge over crizotinib against ROS1+ lung cancer
Crizotinib and entrectinib are both active against ROS1+ non-small cell lung cancer. But which is best? The answer seems easy: Just compare the drugs' clinical trial results. However, not all trials are created equal, and these differences in trial designs can lead to irrelevant comparisons—like comparing athletes' running times without noting that one ran a kilometer while the other ran a mile. Now results from an innovative, "virtual" clinical trial presented at the American Society for Clinical Oncology (ASCO) Annual Meeting 2019 attempt to place crizotinib and entrectinib on an equal playing field. In this analysis, patients taking entrectinib were able to stay on treatment longer and had about almost 6 months longer progression-free survival than patients treated with crizotinib.
* This article was originally published here
* This article was originally published here
MobiKa: A low-cost mobile robot that can assist people in a variety of settings
Researchers at Fraunhofer IPA, in Stuttgart, Germany, have recently developed MobiKa, a low-cost, mobile robot capable of two-modal (voice and text) interactions with humans. Their robot, presented in a paper pre-published on arXiv, could be particularly useful for assisting elderly people.
* This article was originally published here
* This article was originally published here
Subscribe to:
Posts (Atom)